Abstract Submission Deadline: Dec 16, 2025 - Don’t miss out – Early Bird Registration closes on Dec 18, 2025 - Submit your abstract and secure your spot today!

About us

About Euro Rare Diseases 2026

C2P Forum proudly presents the 2nd European Congress on Rare Diseases and Orphan Drugs, set to take place on September14-15, 2026 in London, UK. This two-day event uniting researchers, clinicians, industry leaders, policymakers, and patient advocates from across the globe.

This congress will provide a dynamic platform to explore the latest innovations, challenges, and breakthroughs in rare disease research and orphan drug development. With the aim of fostering collaboration, raising awareness, and accelerating progress, the event will highlight real-world solutions to improve the lives of those affected by rare diseases.

The program will feature keynote lectures, plenary sessions, panel discussions, interactive workshops, and networking opportunities, along with an exhibition showcasing emerging technologies and therapies.

Altogether Euro Rare Diseases is a key event focused on advancing research, encouraging innovation, and enhancing the well-being of people living with rare diseases.

Join us in London for an inspiring gathering that will advance research, strengthen partnerships, and shape the future of rare disease care and global health. Register now to secure your place at this landmark event!

Why to Attend

  • Stay informed on cutting-edge research, diagnostics, and treatment developments in the rare disease landscape.
  • Enhance your professional practice through expert-led sessions focusing on real-world challenges and innovative solutions.
  • Engage with top researchers, clinicians, industry leaders, patient advocates, and policymakers from around the world.
  • Explore new drug development strategies, targeted therapies, and breakthrough medical technologies.
  • Participate in sessions designed to deepen your understanding of rare disease mechanisms, care models, and regulatory pathways.
  • Present your research or projects and help shape the future direction of rare disease care and orphan drug innovation.

Who Can Attend

Academic experts
Healthcare professionals (doctors, nurses, genetic counselors)
Pharmaceutical & Biotechnology Professionals
Researchers
Regulators & Policymakers
Patient advocates
Industrial Stakeholders
Market Access Consultants
Rare Disease Community